CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

Nicholas Investment Partners, LP's Holding History (CIK: 0001389574)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024

Shares 127,283 Value ($000) $6,508 Avg Close $55.95 Range $49.48 - $62.53

Q3 2024

Shares 93,860 Value ($000) $4,796 Avg Close $51.57 Range $43.71 - $55.78

Q2 2024

Shares 53,012 Value ($000) $2,374 Avg Close $46.18 Range $41.01 - $53.70

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2024	127,283	$6,508	$55.95	$49.48 - $62.53
Q3 2024	93,860	$4,796	$51.57	$43.71 - $55.78
Q2 2024	53,012	$2,374	$46.18	$41.01 - $53.70